PREPARING FOR THE GROWING CARE NEEDS OF THE FUTURE
Pulmonary Hypertension is a disease that has largely fallen through the cracks of the major specialities in both Australia and New Zealand. We are seeing an increase in patients presenting with Pulmonary Hypertension, including its rarest form, Pulmonary Arterial Hypertension (PAH).
The Pulmonary Hypertension Society of Australia and New Zealand is committed to supporting sustainable models of care for patients in the future.
Clinical Trials
For patients, carers, clinicians, researchers, and industry partners to access information about pulmonary hypertension clinical trials.
Patient Support
Find out more about PH wellness and education services that are available to assist patients and their families.
